Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Efficacy and safety of a new ready-to-use recombinant human growth hormone solution.
Journal of endocrinological investigation·2007
Same author
Genetic variants in the promoter region of the IGF-I gene as a reason for short stature.
Journal of pediatric endocrinology & metabolism : JPEM·2006
Same author
Surgical anatomy of the cervical sympathetic trunk.
Clinical anatomy (New York, N.Y.)·2005
Same author
The morphological and morphometric features of the scaphoid.
Journal of hand surgery (Edinburgh, Scotland)·2004
Same author
Growth hormone treatment in pituitary insufficiency: selected cases of children with craniopharyngioma and medulloblastoma.
Roczniki Akademii Medycznej w Bialymstoku (1995)·2004
Same author
[Effect of splenectomy on intra- and extraperitoneal tumor growth with reference to the immune system in a rat model].
Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress·2003
Same journal
On the utility of ChatGPT in conducting a literature review on deep learning for dopamine transporter SPECT with [¹²³I]ioflupane.
Nuklearmedizin. Nuclear medicine·2026
Same journal
McCune-Albright Syndrome with Extensive Fibrous Dysplasia Evaluated by 18F-FDG PET/CT and Whole-body Bone Scintigraphy: A Case Report.
Nuklearmedizin. Nuclear medicine·2026
Same journal
False-Positive Rib Lesion on Bone Scintigraphy and 68Ga-PSMA PET/CT: Fibrous Dysplasia Mimicking Metastasis.
Nuklearmedizin. Nuclear medicine·2026
Same journal
PSMA-exprimierende Nebennierenläsion beim Prostatakarzinom: Phäochromozytom statt Metastase.
Nuklearmedizin. Nuclear medicine·2026
Same journal
A translational journey in Germany: From literature to local implementation of [89Zr]Zr-DFO-trastuzumab.
Nuklearmedizin. Nuclear medicine·2026
Same journal
[68Ga]Ga-FAPI-04 PET/CT Delineates Peritoneal Carcinomatosis in Invasive Lobular Breast Cancer with Limited FDG Avidity.
Nuklearmedizin. Nuclear medicine·2026


